UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

A phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor alpha Inhibitor in Patients with Metastatic Breast Cancer

Forster, MD; Madhusudan, S; Muthuramalingam, SR; Braybrooke, JP; Wilner, S; Kaur, K; Han, C; ... Harris, AL; + view all (2004) A phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor alpha Inhibitor in Patients with Metastatic Breast Cancer. Clin Cancer Res. , 10 (19) pp. 6528-6534.

Full text not available from this repository.
Type: Article
Title: A phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor alpha Inhibitor in Patients with Metastatic Breast Cancer
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: http://discovery.ucl.ac.uk/id/eprint/1367163
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item